Mr Gennady A. Gorel > Dechert LLP > Philadelphia, United States > Lawyer Profile
Dechert LLP Offices

CIRCA CENTRE, 2929 ARCH STREET
PA 19104-2808
United States
- Firm Profile
- Go to...
Mr Gennady A. Gorel

Work Department
Finance & Real Estate
Career
Gennady A. Gorel focuses his practice on representing participants in the commercial and residential mortgage markets. He is regularly involved in structuring and negotiating mortgaged-backed securitizations, warehouse lines, loan sale transactions and intercreditor arrangements.
Mr. Gorel’s securitization experience includes commercial mortgaged-backed securities (CMBS), commercial real estate collateralized loan obligations (CRE CLOs), single-family residential (SFR) securitizations, residential mortgage-backed securities (RMBS), non-performing asset securitizations and re-securitizations. He regularly represents issuers, underwriters, b-buyers, loan sellers and servicers in connection with such transactions.
Mr. Gorel also has substantial experience working with a variety of warehouse structures, including repurchase facilities, credit facilities and variable funded note transactions.
Mr. Gorel is an active participant in industry trade organizations such as the CRE Finance Council (CREFC).
Education
Rutgers, The State University of New Jersey, B.S., 2003; Rutgers School of Law – Camden, J.D., 2006, Internet Editor of the Rutgers Law Journal
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade and national security > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Tax > International tax
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Financial services litigation